Miguel Escobar, MD
Hospitalist · Indianapolis, INNPI 1376644856
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (51.2%), speaking fees and education — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by CSL Behring at 48.5% of the total. Among hospitalist clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 38 payments — averaging $28.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$523
- Pfizer$135
- AbbVie$126
- Actelion Pharmaceuticals US, Inc.$69
- Johnson & Johnson$38
- Philips North America LLC$33
- plus $153 from 9 others
What the payments were for
- Speaking & faculty fees$52349%
- Food & beverage$55251%
- Education$30%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 1 | $523 |
| Pfizer | 13 | $135 |
| AbbVie | 5 | $126 |
| Actelion Pharmaceuticals US, Inc. | 3 | $69 |
| Johnson & Johnson | 3 | $38 |
| Philips North America LLC | 2 | $33 |
| AstraZeneca(2 entities) | 2 | $31 |
| Boehringer Ingelheim | 2 | $24 |
| La Jolla Pharmaceutical Company | 1 | $24 |
| Shire North American Group Inc | 1 | $19 |
| Mylan Specialty L.p. | 1 | $16 |
| Merck | 1 | $14 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $11 |
| Paratek Pharmaceuticals, Inc. | 1 | $11 |
| Travere Therapeutics, Inc. | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HEMGENIX$523
How this compares
$1,079 in reported general payments places this provider in the 90th percentile of 423 hospitalist providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 15 | $174 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $83 |
| Cephalexin | 13 | $83 |
| Amlodipine Besylate | 15 | $75 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Indianapolis
- Jai Kumar KhatriIndianapolis$4K
- Andrew PannabeckerIndianapolis$2K
- Edward StephensIndianapolis$1K
- Christopher MoneIndianapolis$1K
- Christine RubeizIndianapolis$767
- Luis NunezIndianapolis$713
- Joseph AbdayemTerre Haute$13K
- James KruegerEvansville$11K
- Yu LiuDecatur$6K
- Laarni MorenoElkhart$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.